Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00251602 · ClinicalTrials.gov registry record · Phase 1

Analysis of Atropine and Propranolol Induced Changes

A Phase 1 study of Healthy, sponsored by National Institute on Aging (NIA).

Completed
Registry status
Phase 1
Development phase
24
Enrollment target
1
Study location

NCT00251602 is a Phase 1 study of Healthy that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 24 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00251602, a Phase 1 study of Healthy, has completed, sponsored by National Institute on Aging (NIA).

COMPLETED
Registry status
Phase 1
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to learn the effects of genetic make up on response to the drugs atropine and propranolol, to examine how changes in heart rate and blood pressure can be measured, and to test a new statistical analysis method.

Conditions Studied

Interventions

  • DRUG Normal Saline
  • DRUG Propranolol
  • DRUG Atropine

Study Locations (1)

Maryland

  • National Institute on Aging, Harbor Hospital - Baltimore

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2003-03
Est. Completion 2012-08
Phase Phase 1

Sponsor

National Institute on Aging (NIA)

131 total trials

What the Registry Record Tells You About NCT00251602

The ClinicalTrials.gov registry entry for NCT00251602 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The listed sponsor is National Institute on Aging (NIA), which has 131 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 3 interventions - of which Normal Saline is the first listed.

NCT00251602 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT00251602 about?

NCT00251602 is a clinical study titled "Analysis of Atropine and Propranolol Induced Changes". The purpose of this study is to learn the effects of genetic make up on response to the drugs atropine and propranolol, to examine how changes in heart rate and blood pressure can be measured, and to test a new statistical analysis method.

What is the current status of trial NCT00251602?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2003-03. Estimated completion is 2012-08.

What conditions does trial NCT00251602 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT00251602?

The interventions under investigation include: Normal Saline (DRUG), Propranolol (DRUG), Atropine (DRUG).

Who is sponsoring clinical trial NCT00251602?

This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00251602 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.